Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Orexigen Therapeutics, Inc. | 252,000 | reported | 13 Oct 2017 | tx 52+13,310,217−3,711,600 |
| Celladon Corp | 50,000 | reported | 04 Jun 2015 | tx 3+82,500 |
| Ultragenyx Pharmaceutical Inc. | 14,058 | reported | 14 May 2026 | tx 24+139,416 |
| ADVANCED MAGNETICS INC | 7,600 | reported | 23 May 2013 | tx 15+81,497 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 7,751 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,058 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,740 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 10,787 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,345 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 9,900 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,860 | 0.00 USD | |
| 07 Jun 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 7,110 | 0.00 USD | deriv |
| 24 Jun 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,300 | 0.00 USD | |
| 24 Jun 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 6,245 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,145 | 0.00 USD | |
| 24 Jun 2021 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 4,125 | 0.00 USD | deriv |
| 26 Jun 2020 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,550 | 0.00 USD | |
| 26 Jun 2020 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 4,250 | 0.00 USD | deriv |
| 11 Jun 2019 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,000 | 0.00 USD | |
| 11 Jun 2019 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,000 | 0.00 USD | deriv |
| 19 Jun 2018 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,000 | 0.00 USD | |
| 19 Jun 2018 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,000 | 0.00 USD | deriv |
| 13 Oct 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 252,000 | 0.00 USD | deriv |
| 22 Jun 2017 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 1,875 | 0.00 USD | |
| 22 Jun 2017 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,750 | 0.00 USD | deriv |
| 31 May 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 626 | 1.55 USD | |
| 03 Feb 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 157,500 | — | deriv |
| 03 Feb 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 315,000 | — | deriv |
| 30 Nov 2016 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 802 | 1.67 USD |
1 purchase reported after at least 12 months of silence — most recent on 04 Feb 2014.